Követés
John L Sullivan
Cím
Hivatkozott rá
Hivatkozott rá
Év
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
W Li, MJ Moore, N Vasilieva, J Sui, SK Wong, MA Berne, ...
Nature 426 (6965), 450-454, 2003
69752003
Changes in thymic function with age and during the treatment of HIV infection
DC Douek, RD McFarland, PH Keiser, EA Gage, JM Massey, BF Haynes, ...
Nature 396 (6712), 690-695, 1998
23001998
Severe herpesvirus infections in an adolescent without natural killer cells
CA Biron, KS Byron, JL Sullivan
New England Journal of Medicine 320 (26), 1731-1735, 1989
16201989
Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
F Kirchhoff, TC Greenough, DB Brettler, JL Sullivan, RC Desrosiers
New England Journal of Medicine 332 (4), 228-232, 1995
13111995
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
RS Sperling, DE Shapiro, RW Coombs, JA Todd, SA Herman, ...
New England Journal of Medicine 335 (22), 1621-1629, 1996
10721996
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
VJ Merluzzi, KD Hargrave, M Labadia, K Grozinger, M Skoog, JC Wu, ...
Science (New York, NY) 250 (4986), 1411, 1990
10381990
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
DD Richman, D Havlir, J Corbeil, D Looney, C Ignacio, SA Spector, ...
Journal of virology 68 (3), 1660-1666, 1994
7551994
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States
A Kwan, RS Abraham, R Currier, A Brower, K Andruszewski, JK Abbott, ...
Jama 312 (7), 729-738, 2014
7162014
Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1
SL Gortmaker, M Hughes, J Cervia, M Brady, GM Johnson, GR Seage III, ...
New England Journal of Medicine 345 (21), 1522-1528, 2001
5842001
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
5722008
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus
DW Hanto, G Frizzera, DT Purtilo, K Sakamoto, JL Sullivan, ...
Cancer research 41 (11_Part_1), 4253-4261, 1981
5641981
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
ME Sharkey, I Teo, T Greenough, N Sharova, K Luzuriaga, JL Sullivan, ...
Nature medicine 6 (1), 76-81, 2000
5122000
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial
A Dorenbaum, CK Cunningham, RD Gelber, M Culnane, L Mofenson, ...
Jama 288 (2), 189-198, 2002
5102002
Proposed definitions for in utero versus intrapartum transmission of HIV-1.
YJ Bryson, K Luzuriaga, JL Sullivan, DW Wara
4951992
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection
D Havlir, SH Cheeseman, M Mclaughlin, R Murphy, A Erice, SA Spector, ...
Journal of Infectious Diseases 171 (3), 537-545, 1995
3851995
Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo
D Hochberg, JM Middeldorp, M Catalina, JL Sullivan, K Luzuriaga, ...
Proceedings of the National Academy of Sciences 101 (1), 239-244, 2004
3632004
ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
LA Pinto, J Sullivan, JA Berzofsky, M Clerici, HA Kessler, AL Landay, ...
The Journal of clinical investigation 96 (2), 867-876, 1995
3201995
Frequency of'chronic active Epstein-Barr virus infection'in a general medical practice
D Buchwald, JL Sullivan, AL Komaroff
Jama 257 (17), 2303-2307, 1987
2991987
Deficient natural killer cell activity in X-linked lymphoproliferative syndrome
JL Sullivan, KS Byron, FE Brewster, DT Purtilo
Science 210 (4469), 543-545, 1980
2921980
Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection
K Luzuriaga, Y Bryson, P Krogstad, J Robinson, B Stechenberg, ...
New England Journal of Medicine 336 (19), 1343-1349, 1997
2841997
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20